Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example
Recent nanotechnology research has been enhancing or creating new applications that have the potential to advance the diagnosis or therapy of diseases. These contributions to the field of nanomedicine have so far been focused on creating the new technologies rather than focusing on particular diseas...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2013-08-01
|
| Series: | Nanotechnology Reviews |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/ntrev-2013-0008 |
| _version_ | 1818580755696058368 |
|---|---|
| author | Youkhanna Joseph Syoufjy Joan Rhorer Mary Oladeinde Oyebola Zeineldin Reema |
| author_facet | Youkhanna Joseph Syoufjy Joan Rhorer Mary Oladeinde Oyebola Zeineldin Reema |
| author_sort | Youkhanna Joseph |
| collection | DOAJ |
| description | Recent nanotechnology research has been enhancing or creating new applications that have the potential to advance the diagnosis or therapy of diseases. These contributions to the field of nanomedicine have so far been focused on creating the new technologies rather than focusing on particular diseases in order to improve their outcomes. For the latter to occur, we recommend the following: (1) creation of interdisciplinary research funding that awards collaborations between biological, medical, clinical, and pharmaceutical scientists with their colleagues in engineering, physics, and chemistry, (2) increasing the training of bio- and medical students in the field of nanotechnology, and (3) focusing on specific diseases for creating nano-based solutions. In this review, we focus on ovarian cancer as an example of a disease that could benefit from advances in nanotechnology to enhance its understanding, diagnosis, and therapy. We also stress the need to train biological, medical, clinical, and pharmaceutical students in the field of nanotechnology with presenting results on such training in USA pharmacy schools. |
| first_indexed | 2024-12-16T07:22:38Z |
| format | Article |
| id | doaj.art-87041761cb1d4f0596d7338c4595188b |
| institution | Directory Open Access Journal |
| issn | 2191-9089 2191-9097 |
| language | English |
| last_indexed | 2024-12-16T07:22:38Z |
| publishDate | 2013-08-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Nanotechnology Reviews |
| spelling | doaj.art-87041761cb1d4f0596d7338c4595188b2022-12-21T22:39:35ZengDe GruyterNanotechnology Reviews2191-90892191-90972013-08-012447348410.1515/ntrev-2013-0008Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an exampleYoukhanna Joseph0Syoufjy Joan1Rhorer Mary2Oladeinde Oyebola3Zeineldin Reema4Department of Pharmaceutical Sciences, MCPHS University, 19 Foster Street, Worcester, MA 01608, USADepartment of Pharmaceutical Sciences, MCPHS University, 19 Foster Street, Worcester, MA 01608, USADepartment of Pharmaceutical Sciences, MCPHS University, 19 Foster Street, Worcester, MA 01608, USADepartment of Pharmaceutical Sciences, MCPHS University, 19 Foster Street, Worcester, MA 01608, USADepartment of Pharmaceutical Sciences, MCPHS University, 19 Foster Street, Worcester, MA 01608, USARecent nanotechnology research has been enhancing or creating new applications that have the potential to advance the diagnosis or therapy of diseases. These contributions to the field of nanomedicine have so far been focused on creating the new technologies rather than focusing on particular diseases in order to improve their outcomes. For the latter to occur, we recommend the following: (1) creation of interdisciplinary research funding that awards collaborations between biological, medical, clinical, and pharmaceutical scientists with their colleagues in engineering, physics, and chemistry, (2) increasing the training of bio- and medical students in the field of nanotechnology, and (3) focusing on specific diseases for creating nano-based solutions. In this review, we focus on ovarian cancer as an example of a disease that could benefit from advances in nanotechnology to enhance its understanding, diagnosis, and therapy. We also stress the need to train biological, medical, clinical, and pharmaceutical students in the field of nanotechnology with presenting results on such training in USA pharmacy schools.https://doi.org/10.1515/ntrev-2013-0008diagnosisnanotechnologyovarian cancerpharmaceuticalpharmd studentstherapytraining |
| spellingShingle | Youkhanna Joseph Syoufjy Joan Rhorer Mary Oladeinde Oyebola Zeineldin Reema Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example Nanotechnology Reviews diagnosis nanotechnology ovarian cancer pharmaceutical pharmd students therapy training |
| title | Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example |
| title_full | Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example |
| title_fullStr | Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example |
| title_full_unstemmed | Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example |
| title_short | Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example |
| title_sort | toward nanotechnology based solutions for a particular disease ovarian cancer as an example |
| topic | diagnosis nanotechnology ovarian cancer pharmaceutical pharmd students therapy training |
| url | https://doi.org/10.1515/ntrev-2013-0008 |
| work_keys_str_mv | AT youkhannajoseph towardnanotechnologybasedsolutionsforaparticulardiseaseovariancancerasanexample AT syoufjyjoan towardnanotechnologybasedsolutionsforaparticulardiseaseovariancancerasanexample AT rhorermary towardnanotechnologybasedsolutionsforaparticulardiseaseovariancancerasanexample AT oladeindeoyebola towardnanotechnologybasedsolutionsforaparticulardiseaseovariancancerasanexample AT zeineldinreema towardnanotechnologybasedsolutionsforaparticulardiseaseovariancancerasanexample |